---
title: "MAIA Biotechnology, Inc. (MAIA.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MAIA.US.md"
symbol: "MAIA.US"
name: "MAIA Biotechnology, Inc."
industry: "Biotechnology"
datetime: "2026-05-21T14:40:18.011Z"
locales:
  - [en](https://longbridge.com/en/quote/MAIA.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MAIA.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MAIA.US.md)
---

# MAIA Biotechnology, Inc. (MAIA.US)

## Company Overview

MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [maiabiotech.com](https://maiabiotech.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -3.23 | 305 | - | - | - |
| PB | 2.83 | 238 | 1432.56 | 30.64 | 10.98 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-18T04:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 50% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.25 |
| Highest Target | 14.00 |
| Lowest Target | 10.27 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/MAIA.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/MAIA.US/norm.md)
- [Related News](https://longbridge.com/en/quote/MAIA.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/MAIA.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**